HSI1 26,485.90 +550.49 234.65B
HSCEI1 9,355.97 +192.73 85.09B
Back    Zoom +    Zoom - Block Traded
Singapore's Hummingbird Bioscience Reportedly Plans to List in HK Next Yr
2025-11-06 17:51:42
Singapore's biopharmaceutical company Hummingbird Bioscience is weighing a listing in Hong Kong next year, Reuters' IFR reported, citing sources.

The company, founded in 2015, focuses on developing innovative cancer treatment drugs.
~



AASTOCKS Financial News
Website: www.aastocks.com